By Luigi Boltri, Senior Director, Pharmaceutical Sciences, Business Support & New Technologies, Adare Pharma Solutions
A particularly bitter pediatric macrolide in powder form was brought to Adare for needs beyond just taste masking. The API also needed:
- Fast release due to a narrow absorption window
- A smooth syrup mouthfeel acceptable to children and infants
- Over seven days of taste masking after suspension
- Drug loading suitable for its high dose
By pairing the API with Adare’s industry leading Microcaps technology, all requirements were met and, in most cases, exceeded.